Dr. Royal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
887 Congress St
Ste 400
Portland, ME 04102Phone+1 207-662-8860Fax+1 207-661-7448- Is this information wrong?
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2001 - 2003
- University of MarylandResidency, Surgery, 1997 - 2000
- University of RochesterFellowship, Surgery, 1994 - 1997
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1993 - 1994
- Cincinnati Children's Hospital Medical CenterFellowship, Research - Pediatric Surgery, 1991 - 1993
- Wellspan Health/York HospitalResidency, Surgery, 1988 - 1991
- Oregon Health and Science University School of MedicineClass of 1988
Certifications & Licensure
- ME State Medical License 2019 - 2026
- OR State Medical License 2019 - 2025
- TX State Medical License 2001 - 2021
- OH State Medical License 1991 - 2002
- PA State Medical License 1990 - 1992
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial Start of enrollment: 2006 Apr 01
- Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer Start of enrollment: 2007 Sep 01
- Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist Start of enrollment: 2010 May 20
- Join now to see all
Publications & Presentations
PubMed
- Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Ben...Neal Bhutiani, Travis E Grotz, Seth J Concors, Michael G White, Beth A Helmink, Kanwal P Raghav, Melissa W Taggart, Karen A Beaty, Richard E Royal, Michael J Overman, ...> ;Annals of Surgical Oncology. 2024 Jan 1
- 28 citationsEfficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal MesotheliomaKanwal Pratap Singh Raghav, Suyu Liu, Michael J. Overman, Anneleis Willett, Mark Knafl, Szu-Chin Fu, Anais Malpica, Seema Prasad, Richard E. Royal, Christopher P. Scal...> ;Cancer Discovery. 2021 Jul 14
- 11 citationsMalignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases.Anais Malpica, Elizabeth D. Euscher, Mario L. Marques-Piubelli, Maria C. Ferrufino-Schmidt, Roberto N. Miranda, Ralph Sams, Richard E. Royal, Kanwal Pratap Singh Ragha...> ;The American Journal of Surgical Pathology. 2021 Jan 1
- Join now to see all
Journal Articles
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
Press Mentions
- Staying Positive in the Face of UncertaintyNovember 30th, 2018
Professional Memberships
- Member
Hospital Affiliations
- Maine Medical CenterPortland, Maine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: